FDA
label_change
· 2023-08-29
FDA Approved: RYALTRIS — Supplemental Application (HIKMA SPECIALTY USA INC.)
Summary
FDA approved a supplemental application for RYALTRIS (olopatadine hydrochloride and mometasone furoate) submitted by Hikma Specialty USA Inc., for labeling chan…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for RYALTRIS (OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE)